We know what’s coming and we are prepared.
Ozempic's Dark Side: 45% Increased Risk of Self-Harm Ideation
Semaglutide, marketed as Ozempic and Wegovy, has taken the weight loss world by storm. Originally developed to treat Type 2 diabetes, its dramatic weight loss effects quickly caught attention. However, a study analyzing World Health Organization data raises serious concerns about its safety.
The research reveals a 45% increased risk of suicidal ideation in patients taking semaglutide compared to other medications. This alarming finding suggests the drug's effects on mental health are more significant than previously thought.
While the weight loss results can seem miraculous, it's crucial to understand the many risks before considering this medication. This increased suicide risk warrants urgent investigation. Learn more: https://bit.ly/3OYBgef
America’s bees and beekeepers are losing a valuable ally just when they need its help most.
The U.S. Department of Agriculture plans to soon close the Beltsville Agricultural Research Center, a 6,500-acre agricultural research station in Maryland that is home to the nation’s premier bee research and disease diagnosis hub, the Beltsville Bee Research Lab.
The closure comes at a critical moment for bees. In winter 2025, many beekeepers lost over half their operations as pesticide-resistant varroa mites spread, bringing deadly viruses. The losses have led to low honey production, and soaring fuel costs have made shipping bees cross-country for agricultural pollination increasingly expensive, further stressing the industry.
